logo
Hunter Biden's Ambien claim triggers deeper GOP probe into alleged cover-up of former president's cognition

Hunter Biden's Ambien claim triggers deeper GOP probe into alleged cover-up of former president's cognition

Fox News23-07-2025
Republicans on the House Oversight Committee are now digging into Hunter Biden's implication that an Ambien sleeping pill was responsible for his father's consequential debate performance one year ago, Fox News Digital has confirmed.
The revelation comes as House Oversight Committee Chairman James Comer, R-Ky., is leading an investigation into the alleged cover-up of President Joe Biden's cognitive decline and his administration's potentially unauthorized autopen use for pardons and executive actions.
"He's 81 years old. He's tired as s--t," Hunter Biden told Andrew Callaghan on his "Channel 5" podcast last weekend. "They give him Ambien to be able to sleep. He gets up on the stage, and he looks like he's a deer in the headlights."
But the former president's son later clarified to ABC News that he did not mean Biden was taking Ambien directly before the debate, and he had intended to make a greater point about his father's rigorous travel schedule in the weeks leading up to that disastrous debate night.
"Hunter Biden's claim that 'they gave him Ambien to be able to sleep' raises serious questions," a House Oversight Committee spokesperson told Fox News Digital. "The House Oversight Committee is looking into this as part of its investigation into the cover-up of President Biden's cognitive decline and unauthorized executive actions by White House staff."
Ambien, or zolpidem, is a prescription medication for insomnia. It is intended only for short-term use, according to GoodRx. Common side effects include dizziness, drowsiness, nausea, vomiting, diarrhea, headache, muscle and joint pain, and double or blurry vision.
The medication can also cause memory problems and grogginess during the day, and more serious and rare side effects can include hallucinations, "abnormal thinking and behavior" and "possible increased risk of dementia in older adults," according to GoodRx.
Biden's former chief of staff and a fixture of his re-election campaign, Ron Klain, is expected to participate in a transcribed interview on Thursday before the House Oversight Committee.
In a letter requesting his appearance, Comer quoted Klain as cutting Biden's debate prep short last year "due to the president's fatigue and lack of familiarity with the subject matter," adding that Biden "didn't really understand what his argument was on inflation," citing a POLITICO report from earlier this year.
"If White House staff carried out a strategy lasting months or even years to hide the chief executive's condition—or to perform his duties—Congress may need to consider a legislative response," Comer said, arguing that the scope of Klain's responsibilities in his personal and professional capacities "cannot go without investigation."
Josh Dawsey of The Wall Street Journal, Tyler Pager of The New York Times, and Isaac Arnsdor of The Washington Post describe in their new book, "2024: How Trump Retook the White House and the Democrats Lost America," how during the June 2024 debate "Biden's aides winced as the president started answering the first question."
And backstage, as Biden stumbled over an answer that questionably ended with, "We finally beat Medicare," Klain stood up and announced, "We're f---ed," according to the authors.
When reached for comment to confirm the book's allegation, Klain told Fox News Digital, "I have nothing to add."
A top former Biden administration aide invoked the Fifth Amendment during her closed-door deposition with the House Oversight Committee, Fox News Digital was told.
Annie Tomasini became the third Democratic ex-official to stonewall investigators looking into whether signs of Biden's alleged mental decline were covered up by his inner circle.
The former White House deputy chief of staff was seen entering and exiting the committee room in under an hour, saying nothing to reporters either time.
A source familiar with the discussions told Fox News Digital that she invoked the Fifth Amendment multiple times. Tomasini herself did not answer when Fox News Digital asked if she did so, and her lawyers did not respond to a request for comment.
"Today, the third witness in our investigation into the cover-up of President Biden's cognitive decline and unauthorized executive actions pleaded the Fifth Amendment. There is now a pattern of key Biden confidants seeking to shield themselves from criminal liability for this potential conspiracy," Comer told Fox News Digital.
Tomasini is the third former Biden administration official to come before committee investigators under subpoena, and the fifth to appear overall.
She was meant to appear Friday for a voluntary transcribed interview, but a committee aide previously told Fox News Digital that Tomasini's lawyers had asked Comer to issue a subpoena specifically.
Both prior officials who appeared under subpoena—former White House physician Kevin O'Connor and Anthony Bernal, a longtime aide to former First Lady Jill Biden—also invoked the Fifth Amendment.
Biden's office declined to comment to Fox News Digital about the House GOP probe into his alleged Ambien use.
But a source familiar with the Biden team's thinking regarding the ongoing House Oversight investigation had previously told Fox News Digital that Trump and congressional Republicans are simply seeking "retribution" through a "partisan, coordinated effort."
"It's an attempt to smear and embarrass," the source said. "And their hope is for just one tiny inconsistency between witnesses to appear so that Trump's DOJ [can] prosecute his political opponents and continue his campaign of revenge."
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Trump's nominee to oversee jobs, inflation data faces shower of criticism
Trump's nominee to oversee jobs, inflation data faces shower of criticism

Yahoo

timea minute ago

  • Yahoo

Trump's nominee to oversee jobs, inflation data faces shower of criticism

WASHINGTON (AP) — The director of the agency that produces the nation's jobs and inflation data is typically a mild-mannered technocrat, often with extensive experience in statistical agencies, with little public profile. But like so much in President Donald Trump's second administration, this time is different. Trump has selected E.J. Antoni, chief economist at the conservative Heritage Foundation, to be the next commissioner at the Labor Department's Bureau of Labor Statistics. Antoni's nomination was quickly met with a cascade of criticism from other economists, from across the political spectrum. His selection threatens to bring a new level of politicization to what for decades has been a nonpartisan agency widely accepted as a producer of reliable measures of the nation's economic health. While many former Labor Department officials say it it unlikely Antoni will be able to distort or alter the data, particularly in the short run, he could change the currently dry-as-dust way it is presented. Antoni was nominated by Trump after the BLS released a jobs report Aug. 1 that showed that hiring had weakened in July and was much lower in May and June than the agency had previously reported. Trump, without evidence, charged that the data had been 'rigged' for political reasons and fired the then-BLS chair, Erika McEntarfer, much to the dismay of many within the agency. Antoni has been a vocal critic of the government's jobs data in frequent appearances on podcasts and cable TV. His partisan commentary is unusual for someone who may end up leading the BLS. For instance, on Aug. 4 — a week before he was nominated — Antoni said in an interview on Fox News Digital that the Labor Department should stop publishing the monthly jobs reports until its data collection processes improve, and rely on quarterly data based on actual employment filings with state unemployment offices. The monthly employment reports are probably the closest-watched economic data on Wall Street, and can frequently cause swings in stock prices. When asked at Tuesday's White House briefing whether the jobs report would continue to be released, press secretary Karoline Leavitt said the administration hoped it would be. 'I believe that is the plan and that's the hope,' Leavitt said. Leavitt also defended Antoni's nomination, calling him an 'economic expert' who has testified before Congress and adding that, 'the president trusts him to lead this important department.' Yet Antoni's TV and podcast appearances have created more of a portrait of a conservative ideologue, instead of a careful economist who considers tradeoffs and prioritizes getting the math correct. 'There's just nothing in his writing or his resume to suggest that he's qualified for the position, besides that he is always manipulating the data to favor Trump in some way,' said Brian Albrecht, chief economist at the International Center for Law and Economics. Antoni wrongly claimed in the last year of Biden's presidency that the economy had been in recession since 2022; called on the entire Federal Reserve board to be fired for not earning a profit on its Treasury securities holdings; and posted a chart on social media that conflated timelines to suggest inflation was headed to 15%. His argument that the U.S. was in a recession rested on a vastly exaggerated measure of housing inflation, based on newly-purchased home prices, to artificially make the nation's gross domestic product appear smaller than it was. 'This is actually maybe the worst Antoni content I've seen yet,' Alan Cole of the center-right Tax Foundation said on social media, referring to his recession claim. On a 2024 podcast, Antoni wanted to sunset Social Security payments for workers paying into the system, saying that 'you'll need a generation of people who pay Social Security taxes but never actually receive any of those benefits.' As head of the BLS, Antoni would oversee the release of the consumer price index by which Social Security payments are adjusted for inflation. Many economists share, to some degree, Antoni's concerns that the government's jobs data has flaws and is threatened by trends such as declining response rates to its surveys. The drop has made the jobs figures more volatile, though not necessarily less accurate over time. 'The stock market moves clearly based on these job numbers, and so people with skin in the game think it's telling them something about the future of their investments,' Albrecht said. 'Could it be improved? Absolutely.' Katharine Abraham, an economist at the University of Maryland who was BLS Commissioner under President Bill Clinton, said updating the jobs report's methods would require at least some initial investment. The government could use more modern data sources, she said, such as figures from payroll processing companies, and fill in gaps with surveys. 'There's an inconsistency between saying you want higher response rates and you want to spend less money,' she said, referring to the administration's proposals to cut BLS funding. Still, Abraham and other former BLS commissioners don't think Antoni, if confirmed, would be able to alter the figures. He could push for changes in the monthly press release and seek to portray the numbers in a more positive light. William Beach, who was appointed BLS commissioner by Trump in his first term and also served under Biden, said he is confident that BLS procedures are strong enough to prevent political meddling. He said he didn't see the figures himself until two days before publication when he served as commissioner. 'The commissioner does not affect the numbers,'' Beach said. 'They don't collect the data. They don't massage the data. They don't organize it." Regarding the odds of rigging the numbers, Beach said, 'I wouldn't put it at complete zero, but I'd put it pretty close to zero.'' It took about six months after McEntarfer was nominated in July 2023 for her to be approved. Antoni will likely face stiff opposition from Democrats, but that may not be enough to derail his appointment. Sen. Patty Murray, a senior Democrat from Washington, on Tuesday slammed Antoni as 'an unqualified right-wing extremist' and demanded that the GOP chairman of the Senate Health, Education, Labor and Pensions Committee, Sen. Bill Cassidy of Louisiana, hold a confirmation hearing for him. ___ Associated Press Staff Writers Paul Wiseman and Stephen Groves contributed to this story. Christopher Rugaber And Josh Boak, The Associated Press

Texas Dems to return after Abbott ends special session that included redistricting
Texas Dems to return after Abbott ends special session that included redistricting

Yahoo

timea minute ago

  • Yahoo

Texas Dems to return after Abbott ends special session that included redistricting

Texas House Democrats who left the state to prevent a vote on new congressional maps will return to Texas, feeling they have accomplished their mission of killing the first special session, raising awareness and sparking national backlash about the mid-decade redistricting, multiple sources confirmed to ABC News and ABC station KTRK on Tuesday. ABC News has not confirmed the date that Democrats plan to return or if they will return in a group, though one source told ABC News the House Democrats loosely plan on returning this weekend. Those plans could change, one source noted, if Republicans go back on their word to begin a second special session on Friday. MORE: Texas House Democrats remain out of state as redistricting showdown continues into second week Gov. Greg Abbott and House Speaker Dustin Burrows said Tuesday morning that the chamber will sine die on Friday, rendering the current special session adjourned if Democrats do not return by then. Abbott would then call a second special session 'immediately,' he said in a statement. He indicated the second special session would include every item from the first and potentially additional items -- though his office could not say what those additional items might be Abbott has said he is committed to calling special sessions, which can last a maximum of 30 days, as long as needed to pass the maps. In a news release on Tuesday that did not share specific plans, House Democrats proclaimed victory, saying that they 'have killed this corrupt special session on behalf of Texas families -- exactly what we said we'd do when we left the state.' -KTRK's Tom Abrahams contributed to this report. Solve the daily Crossword

Global Digital Health Market Poised for Robust Growth at a CAGR of ~18% by 2032 Amid Rising Demand for Remote Care
Global Digital Health Market Poised for Robust Growth at a CAGR of ~18% by 2032 Amid Rising Demand for Remote Care

Yahoo

timea minute ago

  • Yahoo

Global Digital Health Market Poised for Robust Growth at a CAGR of ~18% by 2032 Amid Rising Demand for Remote Care

The digital health market is experiencing robust growth, driven by increasing adoption of telemedicine, wearable devices, and AI-powered health solutions. Rising healthcare costs and the need for remote patient monitoring are accelerating digital transformation in healthcare. Governments and private players are investing heavily in digital infrastructure and health IT solutions. With growing consumer demand for personalized and accessible care, the market is expected to expand at a strong CAGR over the coming years. LAS VEGAS, Aug. 12, 2025 /PRNewswire/ -- DelveInsight's Digital Health Market Insights report provides the current and forecast market analysis, individual leading digital health companies' market shares, challenges, Digital Health market drivers, barriers, trends, and key digital health companies such as Siemens Healthcare Private Limited, Cisco Systems, Inc., Oracle Cerner, Altera Digital Health Inc., and others in the market. Digital Health Overview Digital health refers to the use of technology to improve health outcomes, enhance healthcare delivery, and empower patients in managing their well-being. It encompasses a broad range of tools and services, including telemedicine, mobile health apps, wearable devices, electronic health records (EHRs), and artificial intelligence. These innovations are transforming traditional healthcare systems by making care more accessible, personalized, and data-driven. Digital health solutions allow for real-time monitoring, remote consultations, and predictive analytics, which are especially valuable in managing chronic diseases and improving preventive care. Digital Health Regional Market Insights North America is expected to dominate the overall digital health market over the forecast period, driven by a combination of advanced healthcare infrastructure, high adoption of digital technologies, and supportive regulatory frameworks. The region has been at the forefront of digital health innovation, with widespread integration of telemedicine, mobile health apps, EHRs, and AI-driven diagnostics across healthcare systems. Significant investments by public and private stakeholders in digital health startups and platforms have further accelerated market growth in the U.S. and Canada. The United States, in particular, leads the region due to factors such as high healthcare spending, a strong presence of key technology players, and an increasing focus on value-based care. The COVID-19 pandemic also played a pivotal role in boosting the adoption of virtual care solutions, remote patient monitoring, and digital therapeutics. Additionally, government initiatives like the Health Information Technology for Economic and Clinical Health (HITECH) Act and policy support for interoperability have created a conducive environment for digital health expansion. Moreover, the rising prevalence of chronic diseases, an aging population, and the growing demand for personalized and patient-centric care are further fueling the adoption of digital tools in North America. With continuous innovation, favorable reimbursement scenarios, and an increasing emphasis on preventive care, the region is well-positioned to maintain its leading position in the global digital health market. To know more about why North America is leading the market growth in the digital healthcare market, get a snapshot of the Digital Healthcare EHR Marketing Recent Developments in the Digital Health Market In April 2025, Click Therapeutics, Inc., a pioneer in prescription digital therapeutics and software-enhanced drug therapies, received FDA marketing authorization for the first prescription digital therapeutic designed to prevent episodic migraine. In March 2025, EpiWatch, a company focused on epilepsy management using the Apple Watch and a spinout from Johns Hopkins, received FDA 510(k) clearance for its continuous seizure monitoring platform, which leverages the smartwatch to detect and alert users about tonic-clonic seizures. To read more about the best digital health app for blood work, get a snapshot of the key highlights entailed in the Digital Health Market Research Key Players in the Digital Health Market The digital health market is driven by a mix of established tech giants, healthcare companies, and innovative startups that are shaping the future of healthcare delivery. Major players such as Siemens Healthcare Private Limited, Cisco Systems, Inc., Oracle Cerner, Altera Digital Health Inc., Telefonica, Epic, AT&T, AmerisourceBergen, Candela Corporation., GE Healthcare, Samsung Health, MCKESSON CORPORATION, AliveCor, Inc., Acurable, Amwell, OMRON Healthcare, Inc., Apple Inc., SoftServe, AirStrip Technologies, Inc, Epic Systems Corporation, and others are investing heavily in digital health through wearable devices, cloud-based healthcare solutions, artificial intelligence, and health data analytics. Additionally, a wave of health tech startups are also innovating in areas such as chronic disease management, digital therapeutics, and AI-powered virtual consultations, adding further momentum to this rapidly evolving ecosystem. Which MedTech key players in the digital health cancer care are set to emerge as the trendsetter explore @ Oncology Digital Health Digital Health Market Key Factor Analysis Digital Health Market Drivers The digital health market is experiencing robust growth driven by several key factors. There is a rising demand for digital health solutions, particularly for medical conditions that require regular monitoring and follow-ups. This is complemented by the growing integration of artificial intelligence (AI) in healthcare, which is enhancing diagnostic accuracy, treatment personalization, and operational efficiency. Additionally, governments across the globe are launching initiatives to promote digital health in order to improve healthcare accessibility and reach underserved populations. The increasing adoption of remote patient monitoring systems and mobile health applications further fuels market expansion, reflecting a global shift toward more convenient, tech-enabled healthcare delivery. Digital Health Market Restraints and Challenges The digital health market faces several restraints and challenges that could hinder its widespread adoption and growth. Chief among these are privacy concerns, as the handling and sharing of sensitive personal health data raise significant issues around data security and patient confidentiality. Additionally, a lack of awareness and digital literacy among populations in remote and underserved areas limits the effective utilization of digital health solutions. These barriers underscore the need for robust data protection frameworks and targeted education initiatives to ensure equitable access and trust in digital healthcare technologies. Digital Health Market Opportunities The digital health market is poised for significant growth, driven by rapid technological advancements across several key domains. Innovations in 5G are enhancing real-time data transmission and connectivity, enabling more reliable and scalable telehealth and remote monitoring solutions. Simultaneously, the integration of big data and artificial intelligence is revolutionizing healthcare analytics, diagnostics, and personalized medicine by enabling faster, more accurate decision-making. Additionally, advancements in cybersecurity are ensuring safer digital infrastructures, addressing concerns around data privacy and regulatory compliance. Together, these developments are unlocking new opportunities across the digital health ecosystem, from virtual care delivery to intelligent health management platforms. Get a sneak peek at the digital health cybersecurity @ Digital Healthcare Services Market Report Metrics Details Coverage Global Study Period 2022–2032 Digital Health Market CAGR ~18% Digital Health Market Size in 2032 ~USD 486 Billion Key Digital Health Companies Siemens Healthcare Private Limited, Cisco Systems, Inc., Oracle Cerner, Altera Digital Health Inc., Telefonica, Epic, AT&T, AmerisourceBergen, Candela Corporation., GE Healthcare, Samsung Health, MCKESSON CORPORATION, AliveCor, Inc., Acurable, Amwell, OMRON Healthcare, Inc., Apple Inc., SoftServe, AirStrip Technologies, Inc, Epic Systems Corporation, and others Digital Health Market Assessment Digital Health Market Segmentation Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View Interested in knowing the digital health insights? Click to get a snapshot of the Digital Health Market Report Table of Contents 1 Digital Health Market Report Introduction 2 Digital Health Market Executive Summary 3 Competitive Landscape 4 Regulatory Analysis 5 Digital Health Market Key Factors Analysis 6 Digital Health Market Porter's Five Forces Analysis 7 Digital Health Market Layout 8 Digital Health Market Company and Product Profiles 9 KOL Views 10 Project Approach 11 About DelveInsight 12 Disclaimer & Contact Us Related Reports Digital Therapeutics Market Digital Therapeutics Market Insights, Competitive Landscape, and Market Forecast – 2032 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key digital therapeutics companies, including Limbix Health, Inc., GAIA AG, BigHealth, DarioHealth Corp, HYGIEIA, Akili, Inc., Pear Therapeutics (US), Inc., CANARY HEALTH, Noom, Inc., Omada Health Inc., Welldoc, Inc., 2Morrow, Inc., ResMed, Teladoc Health, Inc., Fitbit Health Solutions, Huma, among others. Telemedicine Service Market Telemedicine Service Market Insight, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key telemedicine service companies, including Teladoc Health, Inc., MEDICI, American Well, Doximity, Inc., Practo, DocOnline, MeMD®, iCliniq, HealthTap, Inc., WELL Health Technologies Corp., Vesta Teleradiology, Samsung Health U.S, Rudolf Riester GmbH, SHL Telemedicine, Array Behavioral Care, SOC Telemed, Heidelberg Medical Consultancy & Health Tourism Pvt. Ltd., First Derm, DirectDerm, among others. Telehealth Market Telehealth Market Insight, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key telehealth companies, including Teladoc Health, Inc., Siemens, Cisco Systems, Inc., Koninklijke Philips N.V., IBM Corporation, Medtronic, Cerner Corporation, American Well, AMD Global Telemedicine, Joerns Healthcare., GlobalMed, OncoHealth, Allscripts Healthcare, LLC, Derma2go, SOCTelemed, Inc., Honeywell International Inc., Plantronics, Inc., Carium., Emmaus Life Sciences, Inc., Practo, among others. Healthcare Cybersecurity Market Healthcare Cybersecurity Market Insights, Competitive Landscape, and Market Forecast – 2032 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key healthcare cybersecurity companies, including IBM Corporation, Barracuda Networks, Inc., Forcepoint, Cisco Systems Inc., CrowdStrike Holdings, Inc., Happiest Minds, Palo Alto Networks, Availity, LLC., SentinelOne, HALOCK, Cynerio, KUDELSKI SA, Sophos Ltd., iConnect IT Business Solutions DMCC, illume intelligence, among others. About DelveInsight DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Contact UsShruti Thakur info@ +14699457679https:// Logo: View original content: SOURCE DelveInsight Business Research, LLP Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store